Company intelligence / Profile preview

Terumo Aortic

Inchinnan/Glasgow, Scotland, United Kingdomterumoaortic.com ↗

Ownership: Private
Employees: ~1100
Development stage: Other

Overview

Vascutek—now operating as part of Terumo Aortic—has developed and commercialized advanced surgical grafts and hybrid stent-graft systems for complex aortic diseases. Its flagship product, Thoraflex Hybrid™, has been implanted in thousands of patients worldwide with strong clinical adoption as the gold standard for certain complex thoracic aorta repairs[2][4]. The company’s products are used globally in over two million patients across more than one hundred countries[3].

Therapeutic areas: Cardiovascular
Modalities: DeviceBiologicPolymer-based device
Industry: Surgical Medical Devices

Partnerships

Collaborations with cardiovascular surgeons globally to co-develop devices[2]

Beyond the preview

Go deeper on Terumo Aortic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terumo Aortic.

Explore the full profile